Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology
Recruiting · NCT04662970 · Interventional (participants receive a specific treatment) · Lead sponsor: Medical University Innsbruck
View the official record on ClinicalTrials.gov →Interventions studied
Device programming
What this trial is about
The principal aim is to analyze total left and right ventricular activation time in different CRT device programming algorithms (SyncAV) measured by non-invasive electrophysiology
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- patients after successful implantation of a CRT-D or CRT-P device in whom a cardiac magnetic resonance examination is possible and the device is equipped with the SyncAV® programming software
- left bundle branch block before CRT implantation
- PQ interval ≤ 250 ms before implantation
Exclusion criteria
- high-grade AV block
- any contraindication concerning a safe CMR performance including claustrophobia
- terminal heart failure (NYHA IV) or cardiac decompensation
- life expectancy \< 1 year
- women with child-bearing potential, pregnancy
- drug abusus
Where it is running
1 location listed.
- Medical University Innsbruck - Innsbruck, Tyrol, Austria